Tumores Ginecológicos

Revisão sistemática | Câncer endometrial e mutações BRCA.

9 Ago, 2022 | 16:42h

Endometrial Cancer and BRCA Mutations: A Systematic Review – Journal of Clinical Medicine

 

---

Estudo comparativo internacional baseado no Global Burden of Disease | Tendências globais e incidência e mortalidade específicas da idade para câncer de colo do útero de 1990 a 2019.

2 Ago, 2022 | 13:09h

Global trends and age-specific incidence and mortality of cervical cancer from 1990 to 2019: an international comparative study based on the Global Burden of Disease – BMJ Open

 

---

Revisão de escopo | Tecidos eréteis femininos e disfunção sexual após radioterapia pélvica.

14 Jul, 2022 | 11:40h

Female erectile tissues and sexual dysfunction after pelvic radiotherapy: A scoping review – CA: A Cancer Journal for Clinicians

 

---

Estudo randomizado | Quimioterapia semanal com dose densa no tratamento de primeira linha do câncer de epitélio ovariano, de tubas uterinas e primário de peritônio.

13 Jul, 2022 | 11:57h

Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal cancer treatment (ICON8): overall survival results from an open-label, randomised, controlled, phase 3 trial – The Lancet Oncology

 

Comentário no Twitter

Updated results from the phase III ICON8 trial in 1,566 pts with newly diagnosed stage IC–IV epithelial ovarian, peritoneal or fallopian tube carcinoma reveal no statistically significant difference in OS with 3-weekly vs weekly carboplatin & paclitaxel: https://t.co/czgH7uGxjt

— NatureRevClinOncol (@NatRevClinOncol) June 15, 2022

 

---

Estudo randomizado | Efeito de apatinibe com doxorrubicina lipossomal peguilada vs. doxorrubicina lipossomal peguilada isoladamente sobre o câncer ovariano recidivante resistente à platina.

4 Jul, 2022 | 11:30h

Effect of Apatinib Plus Pegylated Liposomal Doxorubicin vs Pegylated Liposomal Doxorubicin Alone on Platinum-Resistant Recurrent Ovarian Cancer: The APPROVE Randomized Clinical Trial – JAMA Oncology

Ver também: Visual Abstract

---

Diretriz ESMO | Diagnóstico, tratamento e seguimento do câncer endometrial.

19 Jun, 2022 | 13:27h

Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up – Annals of Oncology

---

Estudo confirma que o rastreamento a cada 5 anos é seguro para mulheres com teste negativo para HPV.

16 Jun, 2022 | 13:06h

Comunicado de imprensa: Screening every five years safe for women who test negative for HPV, study confirms – King’s College London

Estudo original: Extension of cervical screening intervals with primary human papillomavirus testing: observational study of English screening pilot data – The BMJ

Editorial: HPV screening for cervical cancer is reaching maturity – The BMJ

Diretriz OMS relacionada:

Comunicado de imprensa: New recommendations for screening and treatment to prevent cervical cancer – World Health Organization

Ver diretriz: WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention – World Health Organization

Diretriz USPSTF relacionada: Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement – JAMA

---

#ASCO22 – Estudo randomizado | Monoterapia com rucaparibe como tratamento de manutenção para pacientes com câncer de ovário recém-diagnosticado.

14 Jun, 2022 | 12:46h

A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA–MONO/GOG-3020/ENGOT-ov45) – Journal of Clinical Oncology

---

Revisão sistemática de diretrizes para profilaxia do tromboembolismo venoso na oncologia ginecológica.

13 Jun, 2022 | 13:41h

A Systematic Review of the Guidelines on Venous Thromboembolism Prophylaxis in Gynecologic Oncology – Cancers

---

M-A | Associação entre tumores ovarianos benignos e risco de câncer ovariano.

6 Jun, 2022 | 11:05h

Association Between Benign Ovarian Tumors and Ovarian Cancer Risk: A Meta-Analysis of Ten Epidemiological Studies – Frontiers in Oncology

---